Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Dirucotide> ?p ?o }
Showing triples 1 to 62 of
62
with 100 triples per page.
- Dirucotide abstract "Dirucotide (also known as MBP8298) was developed by two research scientists (Dr. Kenneth G. Warren, MD, FRCP(C) & Ingrid Catz, Senior Scientist) at the University of Alberta for the treatment of Multiple Sclerosis (MS). Dirucotide is a synthetic peptide that consists of 17 amino acids linked in a sequence identical to that of a portion of human myelin basic protein (MBP). The sequence of these 17 amino acids isH2N-Asp-Glu-Asn-Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-OH".
- Dirucotide atcPrefix "none".
- Dirucotide casNumber "152074-97-0".
- Dirucotide iupacName "(L)-α-aspartyl-(L)-α-glutamyl-(L)-asparaginyl-(L)-prolyl-(L)-valyl- (L)-valyl-(L)-histidyl-(L)-phenylalanyl-(L)-phenylalanyl-(L)-lysyl- (L)-asparaginyl-(L)-isoleucyl-(L)-valyl-(L)-threonyl-(L)-prolyl- (L)-arginyl-(L)-threonine".
- Dirucotide thumbnail Dirucotide.png?width=300.
- Dirucotide wikiPageID "13327961".
- Dirucotide wikiPageLength "5628".
- Dirucotide wikiPageOutDegree "9".
- Dirucotide wikiPageRevisionID "559441743".
- Dirucotide wikiPageWikiLink Category:Eli_Lilly_and_Company.
- Dirucotide wikiPageWikiLink Category:Multiple_sclerosis.
- Dirucotide wikiPageWikiLink Category:Peptides.
- Dirucotide wikiPageWikiLink Eli_Lilly_and_Company.
- Dirucotide wikiPageWikiLink FDA_Fast_Track_Development_Program.
- Dirucotide wikiPageWikiLink Food_and_Drug_Administration.
- Dirucotide wikiPageWikiLink Medwell_Capital.
- Dirucotide wikiPageWikiLink Myelin_basic_protein.
- Dirucotide wikiPageWikiLink T_cell.
- Dirucotide wikiPageWikiLinkText "Dirucotide".
- Dirucotide wikiPageWikiLinkText "dirucotide".
- Dirucotide atcPrefix "none".
- Dirucotide c "92".
- Dirucotide casNumber "152074".
- Dirucotide h "141".
- Dirucotide iupacName "(L)-α-aspartyl-(L)-α-glutamyl-(L)-asparaginyl-(L)-prolyl-(L)-valyl- (L)-valyl-(L)-histidyl-(L)-phenylalanyl-(L)-phenylalanyl-(L)-lysyl- (L)-asparaginyl-(L)-isoleucyl-(L)-valyl-(L)-threonyl-(L)-prolyl- (L)-arginyl-(L)-threonine".
- Dirucotide kegg "D09396".
- Dirucotide molecularWeight "2013".
- Dirucotide n "25".
- Dirucotide o "26".
- Dirucotide routesOfAdministration "intravenous".
- Dirucotide verifiedrevid "447928420".
- Dirucotide wikiPageUsesTemplate Template:Cascite.
- Dirucotide wikiPageUsesTemplate Template:Drugbankcite.
- Dirucotide wikiPageUsesTemplate Template:Drugbox.
- Dirucotide wikiPageUsesTemplate Template:Keggcite.
- Dirucotide wikiPageUsesTemplate Template:Reflist.
- Dirucotide subject Category:Eli_Lilly_and_Company.
- Dirucotide subject Category:Multiple_sclerosis.
- Dirucotide subject Category:Peptides.
- Dirucotide type Biomolecule.
- Dirucotide type ChemicalSubstance.
- Dirucotide type Company.
- Dirucotide type Drug.
- Dirucotide type Biomolecule.
- Dirucotide type Chemical.
- Dirucotide type Company.
- Dirucotide type Drug.
- Dirucotide type Peptide.
- Dirucotide type Redirect.
- Dirucotide type ChemicalObject.
- Dirucotide type Thing.
- Dirucotide type Q8386.
- Dirucotide comment "Dirucotide (also known as MBP8298) was developed by two research scientists (Dr. Kenneth G. Warren, MD, FRCP(C) & Ingrid Catz, Senior Scientist) at the University of Alberta for the treatment of Multiple Sclerosis (MS). Dirucotide is a synthetic peptide that consists of 17 amino acids linked in a sequence identical to that of a portion of human myelin basic protein (MBP). The sequence of these 17 amino acids isH2N-Asp-Glu-Asn-Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-OH".
- Dirucotide label "Dirucotide".
- Dirucotide sameAs Q1228284.
- Dirucotide sameAs ديروكوتيد.
- Dirucotide sameAs Dirucotid.
- Dirucotide sameAs m.03c1vpc.
- Dirucotide sameAs Q1228284.
- Dirucotide wasDerivedFrom Dirucotide?oldid=559441743.
- Dirucotide depiction Dirucotide.png.
- Dirucotide isPrimaryTopicOf Dirucotide.